netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Paediatric found 52 matches

Formulary items 41 matches
Sub Section Title / notes 1 match
   
Open monograph to display formulary status BNF Category
  Alimemazine Respiratory system - Sedating antihistamines - 03.04.01
  Alteplase Cardiovascular system - Fibrinolytic drugs - 02.10.02
  Aminocaproic acid Cardiovascular system - Antifibrinolytic drugs and haemostatics - 02.11
  Asfotase alfa  (Strensiq®) Nutrition and blood - Drugs used in metabolic disorders - 09.08.01
  Bee and Wasp Allergen Extracts  (Pharmalgen®) Respiratory system - Allergen Immunotherapy - 03.04.02
  Botulinum toxin type A Gastro-intestinal system - Management of anal fissures - 01.07.04
  Botulinum Toxin Type A  (Botox®) Central nervous system - Drugs used in essential tremor, chorea, tics, and related disorders - 04.09.03
  Calcium Carbonate Nutrition and blood - Phosphate-binding agents - 09.05.02.02
  Captopril Cardiovascular system - Angiotensin-converting enzyme inhibitors (ACE inhibitors) - 02.05.05.01
  Cefixime Infections - Cephalosporins - 05.01.02.01
  Chlorothiazide 250mg in 5ml suspension Cardiovascular system - Thiazides and related diuretics - 02.02.01
  Clonidine 150 microgram in 1ml injection Cardiovascular system - Centrally acting antihypertensive drugs - 02.05.02
  Clopidogrel 75mg in 5ml suspension Cardiovascular system - Antiplatelet drugs - 02.09
  Colecalciferol Nutrition and blood - Vitamin D - 09.06.04
  Del Nido Cardioplegia Solution Miscellaneous Preparations [non-BNF and Unlicensed Drugs] - Other - 19
  Dexmedetomidine  (Dexdor®) Anaesthesia - Other drugs for sedation - 15.01.04.04
  Grass and Tree Pollen Extract  (Pollinex Quattro®) Respiratory system - Allergen Immunotherapy - 03.04.02
  Grass and Tree Pollen Extract  (Pollinex®) Respiratory system - Allergen Immunotherapy - 03.04.02
  Infliximab  (Remsima®, Inflectra®, Remicade® ) Musculoskeletal and joint diseases - Cytokine modulators - 10.01.03
  Insulin degludec  (Tresiba®)
(Long acting) 		Endocrine system - Intermediate- and long-acting insulins - 06.01.01.02
  Levosimendan Cardiovascular system - Inotropic sympathomimetics - 02.07.01
  Lidocaine Anaesthesia - Lidocaine - 15.02
  Lorazepam Central nervous system - Drugs used in status epilepticus - 04.08.02
  Macrogol oral powder Gastro-intestinal system - Osmotic laxatives - 01.06.04
  Macrogol oral powder, Compound Gastro-intestinal system - Osmotic laxatives - 01.06.04
  Melatonin Central nervous system - Hypnotics - 04.01.01
  Mepilex® Border lite Wound Care - With absorbent pad - 18.02.03
  Controlled Drug Methylphenidate Central nervous system - CNS stimulants and other drugs used for attention deficit hyperactivity disorder - 04.04
  Misoprostol Gastro-intestinal system - Prostaglandin analogues - 01.03.04
  Paracetamol Central nervous system - Non-opioid analgesics and compound analgesic preparations - 04.07.01
  Phytomenadione Nutrition and blood - Vitamin K - 09.06.06
  Phytomenadione (vitamin K)
(antidote) 		Emergency Treatment of Poisoning - Poisoning - 16
  Plasma-lyte 148 with Glucose 5% Nutrition and blood - Plasma and plasma substitutes - 09.02.02.02
  Rufinamide
(Category 2) 		Central nervous system - Control of epilepsy - 04.08.01
  Simple Linctus Respiratory system - Expectorant and demulcent cough preparations - 03.09.02
  Sodium Picosulfate
(Elixir) 		Gastro-intestinal system - Stimulant laxatives - 01.06.02
  Somatropin (children)
(Growth hormone - children) 		Endocrine system - Anterior pituitary hormones - 06.05.01
  Spironolactone and chlorothiazide capsules Cardiovascular system - Potassium-sparing diuretics with other diuretics - 02.02.04
  Steriflex 165® Nutrition and blood - Parenteral preparations for fluid and electrolyte imbalance - 09.02.02
  Triamcinolone hexacetonide 20mg in 1ml Musculoskeletal and joint diseases - Local corticosteroids injections - 10.01.02.02
  Warfarin Cardiovascular system - Oral anticoagulants - 02.08.02
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in subsection County Durham and Tees Valley Paediatric Asthma Inhaler Guide (Master)
link in drug section MHRA Drug Safety Update (Aug 2022): Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists (03.01.01.01)
link in drug section MHRA Drug Safety Update (Aug 2022): Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists (03.01.01.01)
link in drug section MHRA Drug Safety Update (Aug 2022): Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists (03.01.02)
link in drug section MHRA Drug Safety Update (Oct 2021): Chloral hydrate, cloral betaine (Welldorm): restriction of paediatric indication (04.01.01)
link in drug section MHRA Drug Safety Update (Oct 2021): Chloral hydrate, cloral betaine (Welldorm): restriction of paediatric indication (04.01.01)
link in subsection NENC Paediatric Diabetes Referral Guidelines in Primary Care (06.01)
link in drug section NICE HST23: Asfotase alfa for treating paediatric-onset hypophosphatasia (09.08.01)
link in subsection North Cumbria - Paediatric doses of inhaled corticosteroids (Master)
link in subsection North of Tyne, Gateshead and North Cumbria - Paediatric Asthma Inhaler Guidance (Children under 5 years) (Master)

SubSection Titles / notes  
Drugs affecting the immune response - (08.02)

 
netFormulary